Opiant’s nasal drug spray for opioid overdose gets FDA green light
HQ Team May 23, 2023: The FDA cleared Opiant Pharmaceuticals’ nasal spray to treat opioid overdose in adult and paediatric patients under the.
Drugs
Pharma
Aurobindo to recall two drugs with potential cancer risk
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.